Last updated: 20 August 2024 at 6:48pm EST

Brendan Teehan Net Worth




The estimated Net Worth of Brendan Teehan is at least $1.07 Milione dollars as of 16 August 2024. Mr Teehan owns over 9,534 units of Acadia Pharmaceuticals Inc stock worth over $832,223 and over the last 3 years he sold ACAD stock worth over $237,686.

Mr Teehan ACAD stock SEC Form 4 insiders trading

Mr has made over 15 trades of the Acadia Pharmaceuticals Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently he sold 9,534 units of ACAD stock worth $145,680 on 16 August 2024.

The largest trade he's ever made was exercising 29,738 units of Acadia Pharmaceuticals Inc stock on 17 May 2023 worth over $474,321. On average, Mr trades about 4,528 units every 53 days since 2021. As of 16 August 2024 he still owns at least 52,177 units of Acadia Pharmaceuticals Inc stock.

You can see the complete history of Mr Teehan stock trades at the bottom of the page.





Mr. Brendan Teehan biography

Brendan Teehan is the Exec. VP, COO & Head of Commercial at Acadia Pharmaceuticals Inc.



What's Mr Teehan's mailing address?

Brendan's mailing address filed with the SEC is C/O ACADIA PHARMACEUTICALS INC., 12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130.

Insiders trading at Acadia Pharmaceuticals Inc

Over the last 20 years, insiders at Acadia Pharmaceuticals Inc have traded over $21,409,958 worth of Acadia Pharmaceuticals Inc stock and bought 29,279,665 units worth $647,484,672 . The most active insiders traders include Bros. Advisors Lp14159, L.P..., Bros. Advisors Lp667, L.P.B... e Carl L Gordon. On average, Acadia Pharmaceuticals Inc executives and independent directors trade stock every 17 days with the average trade being worth of $2,248,934. The most recent stock trade was executed by Mark C. Schneyer on 16 August 2024, trading 9,733 units of ACAD stock currently worth $148,720.



What does Acadia Pharmaceuticals Inc do?

acadia pharmaceuticals (nasdaq: acad) is a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in related central nervous system (cns) disorders. all of acadia's product candidates emanate from internal discoveries. we believe that they offer innovative therapeutic approaches that may provide significant advantages relative to current therapies. acadia’s history is rooted in science and strong leadership in cns research. our proprietary drug discovery platform has led to a portfolio of drug candidates with large unmet needs. since the beginning, we have been dedicated to discovering, developing and commercializing innovative therapies that improve the lives of patients suffering from such disorders. acadia is headquartered in san diego. the city represents the second largest biotechnology industry cluster in the united states, home to over 400 companies, as well as the salk institute for biological studies



What does Acadia Pharmaceuticals Inc's logo look like?

Acadia Pharmaceuticals Inc logo

Complete history of Mr Teehan stock trades at Acadia Pharmaceuticals Inc

Data
#
Ditta
Persona
Trans.
Transazione
Azioni Prezzo per azione Prezzo totale Azioni dopo Fonte
16 Aug 2024 Brendan Teehan
EVP, COO e HEAD OF COMMERCIAL
Vendita 9,534 $15.28 $145,680
16 Aug 2024
52,177
1 May 2024 Brendan Teehan
EVP, COO e HEAD OF COMMERCIAL
Opzione 6,814 $17.05 $116,179
1 May 2024
45,610
5 Apr 2024 Brendan Teehan
EVP, COO e HEAD OF COMMERCIAL
Opzione 5,024 $18.01 $90,482
5 Apr 2024
41,364
25 Mar 2024 Brendan Teehan
EVP, COO e HEAD OF COMMERCIAL
Vendita 5,140 $17.90 $92,006
25 Mar 2024
36,340
23 Feb 2024 Brendan Teehan
EVP, COO e HEAD OF COMMERCIAL
Opzione 1,107 $24.78 $27,431
23 Feb 2024
32,056
6 Jan 2024 Brendan Teehan
EVP, COO e HEAD OF COMMERCIAL
Opzione 1,287 $30.33 $39,035
6 Jan 2024
31,680
17 Nov 2023 Brendan Teehan
EVP, COO e HEAD OF COMMERCIAL
Opzione 9,912 $22.84 $226,390
17 Nov 2023
35,353
17 May 2023 Brendan Teehan
EVP, COO e HEAD OF COMMERCIAL
Opzione 29,738 $22.68 $674,458
17 May 2023
39,225
29 Apr 2023 Brendan Teehan
EVP, COO e HEAD OF COMMERCIAL
Opzione 1,567 $21.33 $33,424
29 Apr 2023
10,035
5 Apr 2023 Brendan Teehan
EVP, COO e HEAD OF COMMERCIAL
Opzione 5,024 $18.28 $91,839
5 Apr 2023
10,219
23 Feb 2023 Brendan Teehan
EVP, COO e HEAD OF COMMERCIAL
Opzione 1,107 $19.10 $21,144
23 Feb 2023
5,656
6 Jan 2023 Brendan Teehan
EVP, COO e HEAD OF COMMERCIAL
Opzione 1,286 $17.30 $22,248
6 Jan 2023
5,081
29 Apr 2022 Brendan Teehan
EVP, COO e HEAD OF COMMERCIAL
Opzione 1,567 $18.44 $28,895
29 Apr 2022
3,989
23 Feb 2022 Brendan Teehan
EVP, COO e HEAD OF COMMERCIAL
Opzione 1,106 $24.69 $27,307
23 Feb 2022
2,894
6 Jan 2022 Brendan Teehan
EVP, COO e HEAD OF COMMERCIAL
Opzione 1,286 $23.39 $30,080
6 Jan 2022
2,326


Acadia Pharmaceuticals Inc executives and stock owners

Acadia Pharmaceuticals Inc executives and other stock owners filed with the SEC include: